Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
NCT06411470 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2024-05-13
Summary
The investigators plan to collect throat swabs, saliva, feces and serum samples from pancreatic cancer patients, chronic pancreatitis patients and healthy people and clarify the characteristics of oral flora and serum metabolome of pancreatic cancer patients.
Conditions
- Pancreatic Cancer
- Chronic Pancreatitis
Sponsors & Collaborators
-
Changhai Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-20
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
NCT05596370 ·Status: UNKNOWN
-
Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics
NCT06230432 ·Status: NOT_YET_RECRUITING
-
Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife
NCT02716207 ·Status: COMPLETED ·Phase: NA
-
Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
NCT07036978 ·Status: NOT_YET_RECRUITING
-
Multi-omics Model for Pancreatic Cancer Screening Using cfDNA
NCT06456281 ·Status: RECRUITING
-
Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data Center
NCT05141656 ·Status: UNKNOWN
-
A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
NCT05969171 ·Status: RECRUITING ·Phase: PHASE2
-
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
NCT06873178 ·Status: ACTIVE_NOT_RECRUITING
-
The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients
NCT05168527 ·Status: UNKNOWN ·Phase: PHASE2
-
In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer
NCT05842187 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers Study in Pancreatic Cancer
NCT01666184 ·Status: UNKNOWN
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques
NCT05289895 ·Status: UNKNOWN
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
NCT05088161 ·Status: UNKNOWN
-
Oral Microbiome and Pancreatic Cancer
NCT03302637 ·Status: COMPLETED
-
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
NCT05193162 ·Status: RECRUITING
-
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
NCT05580887 ·Status: UNKNOWN
-
Canagliflozin With Gemcitabine in Pancreatic Carcinoma
NCT05903703 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach
NCT06151691 ·Status: NOT_YET_RECRUITING
-
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
NCT05462496 ·Status: RECRUITING ·Phase: PHASE2
-
Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
NCT03498326 ·Status: RECRUITING ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)
NCT02318147 ·Status: UNKNOWN ·Phase: PHASE1
-
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer
NCT05201729 ·Status: UNKNOWN
-
Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma
NCT04525209 ·Status: UNKNOWN
-
The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
NCT03076502 ·Status: UNKNOWN
-
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT06595160 ·Status: RECRUITING